CLINICAL_TRIALS
trial_result
· 2021-07-19
Clinical Trial Update: Study of a Live Attenuated Chikungunya Vaccine in a Previously Epidemic Area [Phase 2]
Summary
Phase 2 trial update for a live attenuated Chikungunya vaccine completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Themis Bioscience GmbH | Conditions: Chikungunya | Phase 2 | Status: COMPLETED | Results posted: 2021-07-19